Ultravist 300 mg/mL
iopromide · INJECTION · Bayer HealthCare Pharmaceuticals Inc.
No Recall History
Plain English
Ultravist is a injection containing iopromide at 300 mg/mL, taken intra-arterial. Manufactured by Bayer HealthCare Pharmaceuticals Inc..
Key Facts
- Brand Name
- Ultravist
- Generic Name
- iopromide
- NDC Code (Product)
50419-347- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 300 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRA-ARTERIAL, INTRAVENOUS
- Marketing Status
- Application #
- NDA020220
- Drug Class
- Radiographic Contrast Agent [EPC]
- Marketing Start
- 06/08/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Ultravist used for?
Ultravist contains iopromide. It is a injection taken intra-arterial. Consult your doctor for specific uses.
Is Ultravist a controlled substance?
Ultravist is not classified as a controlled substance by the DEA.
What is the generic name for Ultravist?
The generic name for Ultravist is iopromide. There are no other listed brand versions of iopromide.
What is the NDC code for Ultravist 300 mg/mL?
The NDC (National Drug Code) for Ultravist 300 mg/mL is 50419-347, listed by Bayer HealthCare Pharmaceuticals Inc..
Other Ultravist Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)